1. Kohlhepp L.M. et al. Physiological changes during pregnancy // Anaesthesist. 2018. Vol. 67, № 5. P. 383-396.
2. Szecsi P.B. et al. Haemostatic reference intervals in pregnancy // Thromb. Haemost. 2010. Vol. 103, № 4. P. 718-727.
3. Hellgren M. Hemostasis during normal pregnancy and puerperlum // Semin. Thromb. Hemost. 2003. Vol. 29, № 2. P. 125-130.
4. Cerneca F. et al. Coagulation and fibrinolysis changes in normal pregnancy increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis // Eur. J. Obstet. Gynecol. Reprod. Biol. 1997. Vol. 73, № 1. P. 31-36.
5. Heit J. et al. Trends in the Incidence of Venous Thromboembolism during // Ann. Intern. Med. 2005. Vol. 143, № 10. P. 697-706.
6. GHERMAN R.B. et al. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy // Obstet. Gynecol. 1999. Vol. 94, № 5. P. 730-734.
7. Simpson E.L. et al. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database // BJOG An Int. J. Obstet. Gynaecol. 2001. Vol. 108, № 1. P. 56-60.
8. O’Herlihy C. Reviewing maternal deaths to make motherhood safer: 2006-2008 // BJOG An Int. J. Obstet. Gynaecol. 2011. Vol. 118, № 11. P. 1403-1404.
9. Article O. Pregnancy , the postpartum period and prothrombotic defects : risk of venous thrombosis in the MEGA study. 2008. № November 2007. P. 632-637.
10. Sharma S., Monga D. Venous thromboembolism during pregnancy and the post-partum period: Incidence and risk factors in a large Victorian health service // Aust. New Zeal. J. Obstet. Gynaecol. 2008. Vol. 48, № 1. P. 44-49.
11. B0dker B. et al. Maternal deaths in Denmark 2002-2006 // Acta Obstet. Gynecol. Scand. 2009. Vol. 88, № 5. P. 556-562.
12. Clark S.L. et al. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery // Am. J. Obstet. Gynecol. 2008. Vol. 199, № 1. P. 36.e1-36.e5.
13. Samuelsson E., Hellgren M., Hogberg U. Pregnancy-related deaths due to pulmonary embolism in Sweden // Acta Obstet. Gynecol. Scand. 2007. Vol. 86, № 4. P. 435-443.
14. Zotz R.B., Gerhardt A., Scharf R.E. Inherited thrombophilia and gestational venous thromboembolism // Women’s Heal. 2007. Vol. 3, № 2. P. 215-225.
15. Domagala T.B. et al. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease // Blood Coagul. Fibrinolysis. 2002. Vol. 13, № 5. P. 423-431.
16. McColl M.D. et al. Prothrombin 20210 G>A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy // Br. J. Obstet. Gynaecol. 2000. Vol. 107, № 4. P. 565-569.
17. Den Heijer M., Lewington S., Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: A meta-analysis of published epidemiological studies // J. Thromb. Haemost. 2005. Vol. 3, № 2. P. 292-299.
18. Den Heijer M. et al. Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial // Blood. 2007. Vol. 109, № 1. P. 139-144.
19. Robertson L. et al. Thrombophilia in pregnancy: A systematic review // Br. J. Haematol. 2006. Vol. 132, № 2. P. 171-196.
20. Verso M., Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients // J. Clin. Oncol. 2003. Vol. 21, № 19. P. 3665-3675.
21. Flinterman L.E. et al. Current perspective of venous thrombosis in the upper extremity // J. Thromb. Haemost. 2008. Vol. 6, № 8. P. 1262-1266.
22. Paauw J.D. et al. The incidence of PICC line-associated thrombosis with and without the use of prophylactic anticoagulants // J. Parenter. Enter. Nutr. 2008. Vol. 32, № 4. P. 443447.
23. James A.H., Tapson V.F., Goldhaber S.Z. Thrombosis during pregnancy and the postpartum period. 2005. P. 216-219.
24. Bates S.M. et al. Diagnosis of DVT Antithrombotic Therapy and Prevention of Thrombosis , 9th ed : American College of Chest Physicians. 2012. № i.
25. Ataullakhanov F.I. et al. Classic and Global Hemostasis Testing in Pregnancy and during Pregnancy Complications // Semin. Thromb. Hemost. 2016. Vol. 42, № 7. P. 696-716.
26. Gloviczki P. et al. The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum // J. Vasc. Surg. Elsevier Inc., 2011. Vol. 53, № 5 SUPPL. P. 2S-48S.
27. Wittens C. et al. Editor’s choice - Management of chronic venous disease: Clinical practice guidelines of the European Society for Vascular Surgery (ESVS) // Eur. J. Vasc. Endovasc. Surg. Elsevier Ltd, 2015. Vol. 49, № 6. P. 678-737.
28. Le Gal G. et al. Prediction of Pulmonary Embolism in the Emergency Department // Ann. Intern. Med. 2006. Vol. 144, № 3. P. 165-171.
29. Klok F.A. et al. Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism // Arch. Intern. Med. 2008. Vol. 168, № 19. P. 21312136.
30. Syndrome A. P R AC T I C E. 2012. Vol. 120, № 6. P. 1514-1521.
31. Arkel Y.S. Protein Z , protein S levels are lower in patients with thrombophilia and subsequent pregnancy complications. 2005. № April 2004. P. 497-501.
32. Bates S.M. et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: Venous thromboembolism in the context of pregnancy // Blood Adv. 2018. Vol. 2, № 22. P. 3317-3359.
33. Lockwood C.J. et al. The role of decidualization in regulating endometrial hemostasis during the menstrual cycle, gestation, and in pathological states // Semin. Thromb. Hemost. 2007. Vol. 33, № 1. P. 111-117.